Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methionine aminopeptidase (MetAP) is a metalloprotease enzyme that catalyzes the removal of the N-terminal methionine from newly synthesized proteins. It exists in multiple isoforms (e.g., MetAP1 and MetAP2 in humans) and plays a critical role in protein maturation and various cellular processes, including cell cycle progression and angiogenesis. As such, it represents a promising target for anticancer therapy, with inhibitors being developed to block tumor growth and proliferation.
Inhibition of MetAP activity leading to cell cycle arrest and/or anti-angiogenic effects
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methionine Aminopeptidase (MetAP).